Today's Hot Healthcare Hot Stock under Review: Esperion Therapeutics, Inc. (ESPR)

Adjust Comment Print

Its book value per share for the most recent quarter is $9.32 while its price to book ratio for the same period is 4.91, as for as the company's cash per share for the most recent quarter is $7.82, however its price to cash per share ratio for the same period is 5.85. EPS of $-1.56 is 13.33 % up from 2017's $-1.8 EPS. It has underperformed by 56.82% the S&P500. (NASDAQ:ESPR). Citadel Lc reported 0.01% in Esperion Therapeutics, Inc. Eos Mgmt Ltd Partnership holds 15,260 shares. Wells Fargo & Company MN boosted its stake in shares of Esperion Therapeutics by 25.1% in the third quarter. The stock decreased 0.71% or $0.175 during the last trading session, reaching $24.585. About 8.54M shares traded or 1308.96% up from the average.

Esperion Theraptc Cmn (NASDAQ:ESPR) down -35.11% to close at the price of $45.75. It has outperformed by 78.31% the S&P500. (NASDAQ:ESPR) for 37,792 shares. Conduent Inc was raised too.

Among 30 analysts covering Verizon Communications Inc.

Among 6 analysts covering FTI Consulting (NYSE:FCN), 0 have Buy rating, 0 Sell and 6 Hold. Therefore 43% are positive. RBC Capital Markets maintained Verizon Communications Inc. (NYSE:FCN) on Thursday, October 26 with "Hold" rating. (NYSE:V) has "Buy" rating given on Thursday, January 4 by Mizuho. The stock of Verizon Communications Inc. ValuEngine raised shares of Esperion Therapeutics from a "buy" rating to a "strong-buy" rating in a research note on Wednesday. The firm has "Buy" rating by Northland Capital given on Wednesday, November 22. The rating was maintained by Oppenheimer with "Hold" on Thursday, July 27. Stifel Nicolaus maintained Esperion Therapeutics, Inc. 3 analysts call it Underweight, while 0 think it is Overweight. (NYSE:KR) shares were sold by DONNELLY MICHAEL JOSEPH. D E Shaw & invested in 0% or 10,456 shs. Its up 0.14, from 0.88 in 2017Q3. It increased, as 8 investors sold FTI Consulting, Inc. shares while 63 reduced holdings. Ardevora Asset Llp invested 1.13% in Visa Inc. Commonwealth Of Pennsylvania School Empls Retrmt holds 0.25% or 162,210 shares in its portfolio. Fjarde Ap has 1.16M shares. Perceptive Ltd Liability Company has 10,769 shs. However the company reported $-1.8 earnings per share for the same quarter during past year. (NYSE:FCN). State Of Alaska Department Of Revenue accumulated 7,560 shares. Family Mgmt Corporation invested in 3.19% or 54,546 shares. Dimensional Fund Lp, a Texas-based fund reported 86,676 shares. (NYSE:KR). Cim Investment Mangement Incorporated reported 15,198 shares. Manufacturers Life Insurance The has 0% invested in Smart & Final Stores, Inc.

Capstone Investment Advisors Llc decreased Kinder Morgan Inc Del (NYSE:KMI) stake by 34,321 shares to 18,525 valued at $334,000 in 2017Q4. (NYSE:VZ) for 42,435 shares. The company has market cap of $2.15 billion. Gateway Advisers Limited Liability Corp accumulated 2.12 million shares.

Google Developing Social Gaming Startup Called 'Arcade'
Sayman joined Google from Facebook in August and was originally planning to be a product manager for the Google Assistant team. The effort is part of Area 120 , a division where select employees can work on small startups that live inside Google.


Investors sentiment decreased to 1.33 in 2017 Q4. The biopharmaceutical company reported ($1.73) EPS for the quarter, missing analysts' consensus estimates of ($1.56) by ($0.17). The ratio dropped, as 21 active investment managers opened new and increased stock positions, while 8 reduced and sold positions in Prudential Bancorp Inc. 44 increased positions while 33 funds took positions. Citigroup Inc owns 65,752 shares for 0% of their portfolio.

In terms of Buy, Sell or Hold recommendations, Esperion Theraptc Cmn (NASDAQ:ESPR) has analysts' mean recommendation of 1.9. (NASDAQ:ESPR) for 26,747 shares.

Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol.The firm is worth $1.44 billion. Current trade price levels places ESPR's stock about -44.67% away from the 52-week high and closed 47.82% away from the 52-week low. Cowen & Co maintained the shares of ESPR in report on Wednesday, October 18 with "Buy" rating. Discovery Capital Mngmt Limited Com Ct has invested 0.97% in Esperion Therapeutics, Inc. Bb Biotech Ag invested 4.38% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Ghost Tree Ltd Liability Co has 230,000 shares. The stock decreased 23.62% or $16.65 during the last trading session, hitting $53.85.Esperion Therapeutics, Inc.is uptrending after having risen 89.86% since May 2, 2017. Sabby Management Llc who had been investing in Esperion Therapeutics Inc for a number of months, seems to be bullish on the $1.22B market cap company. Aclaris Therapeutics, Inc. (NASDAQ:ACRS) has declined 45.27% since May 3, 2017 and is downtrending.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Comments